跳至主要内容
临床试验/RBR-3byz2c
RBR-3byz2c尚未招募未知

Evatuation of the metabolomic profile of patients with recurrent glioblastoma in treatment with perillyl alcohol intranasal administration associated with the ketogenic diet and dha suplementation

Hospital Universitário Antônio Pedro0 个研究点开始时间: 2018年1月24日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 59Y(—)

入选标准

  • Adults with glioblastoma; submitted to surgical procedure with the partial withdrawal of the tumor; who presented recurrences and are under chemotherapeutic treatment.

排除标准

  • Participants who initiate immunotherapeutic treatment; or develop autoimmune; hepatic or renal disease; or discontinue the ketogenic diet; perillyl alcohol inhalation or supplement will be excluded.

研究者

发起方
Hospital Universitário Antônio Pedro

相似试验